Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Carlos Saiz

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Medicina Clinica|May 10, 2023
Case report: Granulomatosis with polyangiitis (GPA) and facial paralysis after COVID-19 vaccinationLuis Carlos Saiz, María Villanueva Alcojol
The American Journal of Gastroenterology|July 7, 2011
Drug regulatory agencies' role in the interaction between clopidogrel and proton pump inhibitorsLuis Carlos Saiz, Jesús Alvarez, Henar Martínez
BMJ Evidence-Based Medicine|April 14, 2018
When authors lie, readers cry and editors sighLuis Carlos Saiz, Juan Erviti, Javier Garjón
ESC Heart Failure|August 18, 2019
Medical journals and editorial quality controlJuan Erviti, Luis Carlos Saiz, Leire Leache
BMJ Evidence-Based Medicine|December 13, 2025
Ataluren for Duchenne: how politics and social pressure undermined evidence-based decisionsJuan Erviti, Luis Carlos Saiz, Marta Gutiérrez-Valencia
Plos Neglected Tropical Diseases|July 7, 2025
Potential bias in the analysis of prenatal treatment for congenital toxoplasmosisMarta Gutiérrez-Valencia, Luis Carlos Saiz, Juan Erviti
Revista Espanola De Geriatria Y Gerontologia|May 19, 2022
[Review of the validity of fall risk assessment scales in hospitalised patients]Marta Gutiérrez-Valencia, Leire Leache, Luis Carlos Saiz
Medicina Clinica|November 10, 2016
The reliability of clinical trials. The risky way towards drug deregulationJuan Erviti López, Luis Carlos Saiz Fernández, Javier Garjón Parra
Gaceta Sanitaria|July 30, 2020
[Orphan drugs, incentives and uncertainty about their risk-benefit balance]Leire Leache, Luis Carlos Saiz, Marta Gutiérrez-Valencia, et al.
Circulation. Cardiovascular Quality and Outcomes|February 5, 2025
Direct Oral Anticoagulants Versus Warfarin for Atrial Fibrillation in Relation to Time in Therapeutic Range: An Analysis of US Food and Drug Administration Regulatory DataKim Boesen, Luis Carlos Saiz, Peter C Gøtzsche, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Medicina Clinica|May 10, 2023
Case report: Granulomatosis with polyangiitis (GPA) and facial paralysis after COVID-19 vaccinationLuis Carlos Saiz, María Villanueva Alcojol
The American Journal of Gastroenterology|July 7, 2011
Drug regulatory agencies' role in the interaction between clopidogrel and proton pump inhibitorsLuis Carlos Saiz, Jesús Alvarez, Henar Martínez
BMJ Evidence-Based Medicine|April 14, 2018
When authors lie, readers cry and editors sighLuis Carlos Saiz, Juan Erviti, Javier Garjón
ESC Heart Failure|August 18, 2019
Medical journals and editorial quality controlJuan Erviti, Luis Carlos Saiz, Leire Leache
BMJ Evidence-Based Medicine|December 13, 2025
Ataluren for Duchenne: how politics and social pressure undermined evidence-based decisionsJuan Erviti, Luis Carlos Saiz, Marta Gutiérrez-Valencia
Plos Neglected Tropical Diseases|July 7, 2025
Potential bias in the analysis of prenatal treatment for congenital toxoplasmosisMarta Gutiérrez-Valencia, Luis Carlos Saiz, Juan Erviti
Revista Espanola De Geriatria Y Gerontologia|May 19, 2022
[Review of the validity of fall risk assessment scales in hospitalised patients]Marta Gutiérrez-Valencia, Leire Leache, Luis Carlos Saiz
Medicina Clinica|November 10, 2016
The reliability of clinical trials. The risky way towards drug deregulationJuan Erviti López, Luis Carlos Saiz Fernández, Javier Garjón Parra
Gaceta Sanitaria|July 30, 2020
[Orphan drugs, incentives and uncertainty about their risk-benefit balance]Leire Leache, Luis Carlos Saiz, Marta Gutiérrez-Valencia, et al.
Circulation. Cardiovascular Quality and Outcomes|February 5, 2025
Direct Oral Anticoagulants Versus Warfarin for Atrial Fibrillation in Relation to Time in Therapeutic Range: An Analysis of US Food and Drug Administration Regulatory DataKim Boesen, Luis Carlos Saiz, Peter C Gøtzsche, et al.
Pageof 5